Identification of peptides specific for antibodies in vitiligo using a phage library

Clinical and Experimental Dermatology

Volumn 30, Issue 6, 2005, Pages 694-701

  Jadali, Zohreh ^a,e   Eslami, M B ^a   Sanati, M H ^b   Mansouri, P ^c   Mahmoudi, M ^a   Maghsoudi, N ^d   Esfahanian, F ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MALEK ASHTAR UNIVERSITY OF TECHNOLOGY   (Iran)

^e NONE   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; MONOCLONAL ANTIBODY; PEPTIDE; PEPTIDE LIBRARY; POLYCLONAL ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ARTICLE; BACTERIOPHAGE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR MIMICRY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; VITILIGO;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; AUTOANTIBODIES; BACTERIOPHAGE M13; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; EPITOPES; FEMALE; HUMANS; IMMUNOGLOBULINS; MALE; MIDDLE AGED; PEPTIDE LIBRARY; VITILIGO;

EID: 27144476954     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2005.01903.x     Document Type: Article

References (32)

1. Kovacs SO. Vitiligo. J Am Acad Dermatol 1998; 38: 647-66.
2. Ongenae K, Geel NV, Naeyaert J-M. Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res 2003; 16: 90-100.
3. Cui J, Harning R, Henn M, Bystryn J-C. Identification of pigment cell antigens defined by vitiligo antibodies. J Invest Dermatol 1992; 98: 162-5.
4. Gilhar A, Zelickson B, Ulman Y, Etzioni A. In vivo destruction of melanocytes by the IgG fraction of serum from patients with vitiligo. J Invest Dermatol 1995; 105: 683-6.
5. Norris DA, Kissinger RM, Naughton GK, Bystryn JC. Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity (ADCC). J Invest Dermatol 1988; 90: 783-9.
6. Naughton GK, Reggiardo D, Bystryn J-C. Correlation between vitiligo antibodies and extent of depigmentation in vitiligo. J Am Acad Dermatol 1986; 15: 978-81.
7. Harning R, Cui J, Bystryn JC. Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. J Invest Dermatol 1991; 97: 1078-80.
8. Sioud M, Førre Ø, Dybwad A. Selection of ligands for polyclonal antibodies from random peptide libraries. Potential identification of (auto) antigens that may trigger B and T cell responses in autoimmune diseases. Clin Immunol Immunopathol 1996: 79: 105-14.
9. Rowley MJ, Scealy M, Whisstock JC et al. Prediction of the immunodominant epitope of the pyruvate dehydrogenase complex E2 in primary biliary cirrhosis using phage display. J Immunol 2000; 164: 3413-9.
10. Scott JK, Smith GP. Searching for peptide ligands with an epitope library. Science 1990; 249: 386-90.
11. Germaschewski V, Murray K. Identification of polyclonal serum specificities with phage-display libraries. J Virol Methods 1996; 58: 21-32.
12. Birch-Machin I, Ryder S, Taylor L et al. Utilisation of bacteriophage display libraries to identify peptide sequences recognised by equine herpesvirus type 1 specific equine sera. J Virol Methods 2000; 88: 89-104.
13. Iniguez P, Zientara S, Marault M et al. Screening of horse polyclonal antibodies with a random peptide library displayed on phage: identification of ligands used as antigens in an ELISA test to detect the presence of antibodies to equine arteritis virus. J Virol Methods 1998; 73: 175-83.
14. Koivunen E, Arap W, Rajotte D et al. Identification of receptor ligands with phage display peptide libraries. J Nucl Med 1999; 40: 883-8.
15. Cortese R, Monaci P, Nicosia A et al. Identification of biologically active peptides using random libraries displayed on phage. Curr Opin Biotechnol 1995; 6: 73-80.
16. Hudson L, Hay FC. Practical Immunology. Blackwell Scientific Publications, London. 1991: 1-33.
17. Prezzi C, Nuzzo M, Meola A et al. Selection of antigenic and immunogenic mimics of hepatitis C virus using sera from patients. J Immunol 1996; 156: 4504-13.
18. Dybwad A, Førre Ø, Natvig JB, Sioud M. Structural characterization of peptides that bind synovial fluid antibodies from RA patients. A novel strategy for identification of disease-related epitopes using a random peptide library. Clin Immunol Immunopathol 1995; 75: 45-50.
19. Lunardi C, Bason C, Leandri M et al. Autoantibodies to inner ear and endothelial antigens in Cogan's syndrome. Lancet 2002; 360: 915-21.
20. Irving MB, Pan O, Scott JK. Random-peptide libraries and antigen Fragment libraries for epitope mapping and the development of vaccines and diagnostics. Curr Opin Chem Biol 2001; 5: 314-24.
21. Cohen IR, Young DB. Autoimmunity, microbial immunity and the immunological homunculus. Immunol Today 1991; 12: 105-10.
22. Mo JA, Holmdahl R. The B cell response to autologous type II collagen: biased V gene repertoire with V gene sharing and epitope shift. J Immunol 1996; 157: 2440-8.
23. Cwirla SE, Peters EA, Barrett RW, Dower WJ. Peptides on phage: a vast library of peptides for identifying ligands. Proc Natl Acad Sci USA 1990; 87: 6378-82.
24. Luzzago A, Felici F, Tramontano A et al. Mimicking of discontinuous epitopes by phage-displayed peptides. I. Epitope mapping of human H ferritin using a phage library of constrained peptides. Gene 1993; 128: 51-7.
25. Geysen HM, Rodda SJ, Mason TJ. A priori delineation of a peptide which mimics a discontinuous antigenic determinant. Mol Immunol 1986; 23: 709-15.
26. Meloen RH, Puijk WC, Slootstra JW. Mimotopes: realization of an unlikely concept. J Mol Recognit 2000; 13: 352-9.
27. Iverson MV. Hypothesis: vitiligo virus. Pigment Cell Res 2000; 13: 281-2.
28. Castanet J, Ortonne J-P. Pathophysiology of vitiligo. Clin Dermatol 1997; 15: 845-51.
29. Grimes PE, Sevall JS, Vojdani A. Cytomegalovirus DNA indentified in skin biopsy specimens of patients with vitiligo. J Am Acad Dermatol 1996; 35: 21-6.
30. Yamamoto T, Nishioka K. Vitiligo vulgaris associated with hepatitis C virus. J Dermatol 2000; 27: 416-7.
31. Adiloglue AK, Basak PY, Baysal V. Clinical evaluation of vitiligo and its relationship with viral hepatitis. J Eur Acad Dermatol Venerol 2003; 17: 365-6.
32. Akar A, Yapar M, Aksakal B. vitiligo: Cytomegalovirus associated? Pigment Cell Res 2002; 15: 134-5.